Related Experiment Video
Updated: May 7, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Membrane remodeling by α-synuclein and effects on amyloid formation
Zhiping Jiang1, Michel de Messieres, Jennifer C Lee
1Laboratory of Molecular Biophysics, Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, Maryland 20892, United States.
Alpha-synuclein (α-Syn) deforms neutral lipid vesicles into tubules, inhibiting its amyloid formation. This finding offers new insights into Parkinson's disease pathogenesis.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Alpha-synuclein (α-Syn) is intrinsically disordered and linked to Parkinson's disease.
- Its amyloid formation and membrane binding are implicated in pathogenesis, but mechanisms remain unclear.
Purpose of the Study:
- To investigate α-Syn's interaction with neutral lipid membranes and its effect on amyloid formation.
- To elucidate the structural and dynamic consequences of α-Syn binding to phosphatidylcholine (PC) vesicles.
Main Methods:
- Transmission electron microscopy (TEM) to visualize vesicle deformation.
- Circular dichroism (CD) spectroscopy to assess protein secondary structure.
- Time-resolved fluorescence anisotropy using single tryptophan variants to study protein-lipid interactions.
Main Results:
- α-Syn deformed neutral PC vesicles into ~20 nm diameter tubules without significant changes in its secondary structure.
- Vesicle remodeling inhibited α-Syn amyloid formation, affecting both lag and growth phases.
- α-Syn exhibited weak, non-specific interaction with lipid bilayers (Kp ~ 300 M⁻¹).
Conclusions:
- α-Syn-induced membrane remodeling of neutral lipid membranes is a novel mechanism.
- This interaction inhibits α-Syn aggregation, suggesting a role in Parkinson's disease pathogenesis.
- The findings highlight the biological relevance of α-Syn's interaction with PC-rich cellular membranes.
More Related Videos
08:24A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology